SEC Filings
State Street Holds 4.6% Of Twist Bioscience Without Seeking To Influence Control
The holding covers 3,017,072 shares, with Twist scheduled to report fiscal 2026 results Thursday before the market opens.
SEC Filings
The holding covers 3,017,072 shares, with Twist scheduled to report fiscal 2026 results Thursday before the market opens.
SEC Filings
The ownership report comes while Ultragenyx and Mereo discuss a regulatory path for setrusumab in children with osteogenesis imperfecta.
SEC Filings
The steelmaker describes advance collections primarily as credit protection, while receivables absorbed $1.2 billion over nine months.
SEC Filings
The reported position covered 8,214,409 shares, and State Street certified it was not held to influence control.
SEC Filings
The company expects to file within five calendar days of its due date and anticipates no significant year-over-year change in results.
SEC Filings
The reported position totals 1,504,091 common shares in the agricultural-products supplier.
SEC Filings
The 14,433,295-share position comes as commercial shipments begin and material shortages constrain production.
SEC Filings
The holding covers 2,385,094 shares in the defense-services company, whose investment case includes further margin improvement.
SEC Filings
The position covers 3,010,531 common shares, with shared voting authority over 2,938,155 shares.
SEC Filings
Vera's first partial commercial quarter brought $10.3 million in drug sales and a wider net loss.
SEC Filings
Verastem expects October financing and cancer-drug revenue to support operations into the first half of 2028.
SEC Filings
SSGA Funds Management separately reported 5.4% of the common-stock class; the ownership figures date to September 30.